Please check your internet connection and try again.
# Dextromethorphan/Guaifenesin
## Overview
This combination product contains a cough suppressant (dextromethorphan) and an expectorant (guaifenesin).
## Primary Indications
Symptomatic relief of cough and chest congestion associated with the common cold, bronchitis, and other upper respiratory tract conditions.
## Adult Dosing
* **Dextromethorphan:** 10-20 mg every 4 hours, or 30 mg every 6-8 hours. Maximum 120 mg/day.
* **Guaifenesin:** 200-400 mg every 4 hours. Maximum 2400 mg/day.
* *Specific dosing for combination products varies by formulation. Always check the product label.*
## Pediatric Dosing
* **Dextromethorphan:**
* 6-12 years: 5-10 mg every 4 hours, or 15 mg every 6-8 hours. Maximum 60 mg/day.
* Under 6 years: Safety and efficacy not established for combination products. Consult product labeling or pediatrician.
* **Guaifenesin:**
* 6-12 years: 100-200 mg every 4 hours. Maximum 1200 mg/day.
* Under 6 years: Safety and efficacy not established for combination products. Consult product labeling or pediatrician.
* *Dosing for combination products in pediatrics requires careful attention to the specific formulation and age-appropriateness.*
## Dose Adjustments
No specific dose adjustments are typically required for hepatic or renal impairment, but caution is advised, and lower doses may be considered.
## Contraindications
* Hypersensitivity to dextromethorphan or guaifenesin.
* Use with or within 14 days of MAOI therapy (for dextromethorphan).
* Use in patients with persistent or chronic cough, such as that associated with asthma or emphysema, unless directed by a physician (due to potential for bronchodilation masking symptoms).
## Adverse Effects
* **Dextromethorphan:** Dizziness, drowsiness, nausea, vomiting, constipation. Abuse potential exists at higher doses. Serotonin syndrome is a rare but serious risk, especially when combined with serotonergic agents.
* **Guaifenesin:** Nausea, vomiting, stomach pain, dizziness, headache.
## Key Drug Interactions
* **Dextromethorphan:**
* MAO inhibitors: Risk of severe hypertension and serotonin syndrome.
* SSRIs, SNRIs, tricyclic antidepressants, triptans, certain opioids (tramadol, fentanyl), lithium, St. John's wort: Increased risk of serotonin syndrome.
* CYP2D6 inhibitors (e.g., fluoxetine, paroxetine, quinidine): May increase dextromethorphan levels, leading to increased toxicity.
* **Guaifenesin:** Generally considered to have few significant drug interactions.
## Monitoring
* Monitor for therapeutic effectiveness (cough suppression, mucus expectoration).
* Monitor for adverse effects, particularly CNS effects with dextromethorphan and GI upset with guaifenesin.
* Assess for signs of serotonin syndrome if concomitant serotonergic agents are used.
## Clinical Pearls
* Adequate hydration is important to help guaifenesin thin mucus.
* Combination products can lead to overuse or inappropriate dosing if individual components are needed at different strengths or frequencies. Carefully assess if both agents are truly indicated.
* Dextromethorphan is an NMDA receptor antagonist and has abuse potential. Counsel patients on appropriate use and storage.
* Guaifenesin's efficacy in thinning mucus is debated, but it remains a common component of cough and cold preparations.
---
*This information is for educational purposes only and does not constitute medical advice. Always verify current prescribing information with official drug compendia or product labeling before making clinical decisions.*